Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBYI | BCYC | ARMP | ||
| Company | Puma Biotechnology | Bicycle Therapeutics Plc ADR | Armata Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 6.21 | 4.63 | 8.11 | ||
| High | 6.45 | 4.81 | 9.01 | ||
| Low | 6.20 | 4.52 | 7.70 | ||
| Latest | 6.27 | 4.58 | 8.63 | ||
| Change | -0.06 | -0.10 | +0.02 | ||
| % Change | -0.95% | -2.14% | +0.23% | ||
| Volume | 61,347 | 509,873 | 23,481 | ||
| 20-Day Average Volume | 423,000 | 528,294 | 31,226 | ||
| Previous Close | 6.33 | 4.68 | 8.61 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 6.13 | 5.04 | 10.06 | ||
| 20-Day Raw Stochastic | 58.83% | 22.44% | 28.88% | ||
| 20-Day Relative Strength | 49.62 | 37.79 | 48.07 | ||
| Weighted Alpha | +54.55 | -51.50 | +212.59 | ||
| Today's Opinion | 56% Buy | 100% Sell | 72% Buy | ||
| Previous Opinion | 56% Buy | 100% Sell | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 96% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.44% since 03/19/26 | +0.88% since 03/19/26 | +5.55% since 03/19/26 | ||
| Low | 6.07 on 03/20/26 | 4.25 on 03/24/26 | 7.43 on 03/20/26 | ||
| High | 6.52 on 03/25/26 | 4.85 on 03/25/26 | 9.52 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | -17.11% since 02/26/26 | -18.62% since 02/26/26 | -19.21% since 02/26/26 | ||
| Low | 5.50 on 03/02/26 | 4.25 on 03/24/26 | 7.43 on 03/20/26 | ||
| High | 6.86 on 02/27/26 | 5.77 on 03/02/26 | 12.00 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +2.27% since 12/26/25 | -32.70% since 12/26/25 | +32.98% since 12/26/25 | ||
| Low | 5.50 on 03/02/26 | 4.25 on 03/24/26 | 5.66 on 01/15/26 | ||
| High | 7.68 on 02/26/26 | 7.34 on 01/22/26 | 12.23 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | +30.17% since 09/26/25 | -37.97% since 09/26/25 | +190.70% since 09/26/25 | ||
| Low | 4.57 on 11/11/25 | 4.25 on 03/24/26 | 2.94 on 10/02/25 | ||
| High | 7.68 on 02/26/26 | 9.16 on 10/09/25 | 16.34 on 10/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 322,045 | 324,642 | 313,464 | ||
| Shares Outstanding, K | 50,876 | 69,368 | 36,407 | ||
| Annual Sales | 228,370,000 | 72,590,000 | 5,170,000 | ||
| Annual Net Income | 31,110,000 | -218,960,000 | -18,920,000 | ||
| Last Quarter Sales | 75,450,000 | 47,960,000 | 1,160,000 | ||
| Last Quarter Net Income | 13,440,000 | -20,150,000 | -26,680,000 | ||
| 60-Month Beta | 1.26 | 1.65 | 1.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.29 on 02/26/26 | -0.29 on 03/17/26 | -0.42 on 11/12/25 | ||
| Latest Earnings Date | 05/14/26 | 05/07/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.26 | 0.00 | 0.00 | ||